[新聞] WHO的團體疫苗試驗聲明

[skbb2553 (星祈)]

完整標題：WHO Statement on Solidarity Trial Vaccines
發稿單位：WHO(世界衛生組織)
發稿時間：26 October 2021
撰 稿 者：同發稿單位
原文連結：https://bit.ly/3pC2Qyz



WHO and the Ministries of Health of Colombia, Mali, and the Philippines
announce the launch of the co-sponsored Solidarity Trial Vaccines.

關於Solidarity Trail的進一步介紹：https://bit.ly/3jEEQXL

WHO將會資助哥倫比亞衛生部、馬利衛生部、菲律賓衛生部進行團體疫苗試驗

This is an international, randomized clinical trial platform designed to
rapidly evaluate the efficacy and safety of promising new candidate vaccines
selected by an independent vaccine prioritization advisory group composed of
leading scientists and experts.

這是一個國際性、隨機性臨床試驗平台，目的是
經由專業人士和科學家組成的獨立疫苗專家小組選擇新的候選疫苗
並盡快評估安全性和有效性

This announcement comes after the relevant regulatory authorities and ethics
committees have granted approval for the study to progress.

The national principal investigators and their research teams in Colombia,
Mali, and the Philippines have begun recruiting volunteers joining the trial.

本次聲明經由當地相關法律單位和倫理審議委員會審核通過後提出。
臨床試驗主負責人和所屬研究團隊開始應徵受試者做臨床試驗。

The Solidarity Trial Vaccines is beginning with research teams in over 40
trial sites spread across the three countries. National research teams bring
together experienced investigators well-versed in good clinical practice and
the conduct of clinical trials.

團體疫苗試驗將會在三個國家、共40個臨床試驗點進行臨床試驗。
(National research那一句講會做好臨床試驗但我不太會翻)

To date, the independent vaccine prioritization advisory group has reviewed
the evidence of around 20 candidate vaccines. Following the recommendation of
the working group, 2 candidate vaccines are now included in the Solidarity
Trial Vaccines. These are a protein subunit vaccine from Medigen, and a DNA
vaccine encoding the spike protein from Inovio.

到目前為止，獨立疫苗專家小組已經確認約20個候選疫苗的相關證據
經小組建議，把高端的次蛋白疫苗和Inovio的DNA疫苗加入團體疫苗試驗

Two additional vaccines are expected to enter the Solidarity Trial Vaccines
once additional evidence and documentation has been reviewed and accepted as
satisfactory by the independent vaccine prioritization advisory group.

It is expected that other candidate vaccines currently under consideration by
the vaccine prioritization advisory group may be added to the trial in late
2021 and during 2022.

只要相關證據都能證明的話，預期2021年底至2022年還會再加入2支候選疫苗

The Solidarity Trial Vaccines aims to accelerate the evaluation of multiple
promising candidate COVID-19 vaccines, contributing to the creation of a
larger portfolio of vaccines needed to protect people from COVID-19 around
the world. The trial has the additional potential to uncover
second-generation vaccines with greater efficacy, conferring greater
protection against variants of concern, offering longer duration of
protection, and/or using needle-free routes of administration.

(團體疫苗試驗的聲明和目標 整段省略不提應該可以吧....0_0?)


--
※ 發信站: 批踢踢實業坊(ptt.cc), 來自: 220.129.230.29 (臺灣)
※ 文章網址: https://www.ptt.cc/bbs/nCoV2019/M.1635263065.A.EC6.html
※ 編輯: skbb2553 (220.129.230.29 臺灣), 10/27/2021 00:11:40
推 popopal: 原來WHO有玩Artesunate 看來有救了
→ Gjerry: 附加的目標不知道實際上要怎麼完成
→ skbb2553: 一些專家會議的討論我沒有關鍵字不好找
→ skbb2553: 有找到的話我會盡快更新
推 Mgthok68: 謝謝提供資訊和翻譯~
推 allen771115: 一直有好消息傳出
推 judoyang: 高端二期3000人的實驗資料太充足了!外加
→ judoyang: 台灣有做跟AZ的橋接,會被選上不意外!不
→ judoyang: 過WHO這實驗是跟delta戰,能不能過50%有
→ judoyang: 點懸啊!!(現在所有任何國家EUA的疫苗直
→ judoyang: 接對上delta能不能過50%都有疑問)
推 RingoCake: 感謝資訊與翻譯～
→ zaqofi: 能以低副作用但高抗體來供應 也是功德
→ Brotherone: 又大內宣
推 yupei: WHO什麼時候變成大內宣了？不是舔共嗎？
推 bobbyindaeyo: 高端真的很棒！我很多美國朋友都在
→ bobbyindaeyo: 問。有些不打疫苗都是都想飛來台灣
→ bobbyindaeyo: 打
→ houting: 大半夜的用菲律賓跳板只為了酸 真費事啊
推 hit1003: 能被取中真不容易。
推 wardraw: 高端對上delta不弱於AZ的話就算成功了吧
推 tmuaircat: 希望成功 但要解決類似novavax量產問題
推 bradyhau106: 希望一切順利
推 shelley0522: 希望成功
推 p03189: 現在都多到沒人打了哪有量產問題？等WHO實
→ p03189: 驗完，產量更是破表
推 dahlia7357: WHO CAN HELP?XD
推 amyflower: 感謝提供資訊
推 david624: 加油
推 Miahh: 希望有好結果
→ sdiaa: 德國數據現有疫苗對DELTA還是有效的...
→ sdiaa: 現在AZ BNT MODERNA
推 jachan: 早日有國際認證，無論結果好壞，都是解脫
→ jachan: ，成功最好，失敗政府也可以趕快補救，補
→ jachan: 打其他疫苗
→ qoo53895: 謝謝
推 luten: 加油
推 serenemind: 但是台北有對驚世夫妻一直黑高端
→ siyaoran: 對delta的話現有疫苗過不了三期期中
推 Cordierite: 國產疫苗加油
→ JoeyChen: 請問這是免疫橋接還是直接挑戰保護力?
→ sdiaa: 三期的保護力是算相對值不是絕對值
→ sdiaa: 只要DELTA對沒打疫苗也是超會傳還是會過50%
推 Nicole282383: 謝謝分享，若有好的疫苗副作用低，
→ Nicole282383: 對於全世界來說是福音
→ sdiaa: 有打疫苗感染率10/萬 沒打感染率100/萬 90%
→ sdiaa: 如果是1000/萬:10000/萬 還是90%保護力 XD
→ sdiaa: 多傳染給有打疫苗 少傳給沒打疫苗 才會逆轉
推 edu4841: 這算是who幫忙出錢做第三期嗎？
→ skbb2553: 個人理解是WHO資助國家去展開相關實驗
→ Guyinkt: 意思就是「不一定」，對嗎？
→ skbb2553: ？？？？
→ skbb2553: WHO資助的實驗 至少要WHO出錢出疫苗吧
→ zaqofi: WHO聲明附聯絡信箱 對資金疑問的寫信問阿
→ vicklin: 受試地有菲律賓也有就近照顧鄰居的感覺
推 purewind: 全球不到一半的人打過兩劑疫苗，不會沒
→ purewind: 人要打
推 za9865: 希望能成功 保存條件容易的優勢很適合送往
→ za9865: 窮困國家